USPTO Announces Notice of Proposed Rulemaking for Claim Construction Standard used in PTAB Proceedings

May 8, 2018

Now Available! Seyfarth Shaw’s BioLoquitur Bulletin: Drugs Available in 2018 for Generic Competition

April 5, 2018

Webinar: Bridging the Gap Between EU and U.S. Biotech Inventions Protection

February 22, 2018

Now Available! Seyfarth Shaw’s Hatch-Waxman and Biosimilars Litigation: 2017 Year-in-Review

February 8, 2018

Will Blockchain Revolutionize Bio/Pharma R&D, Tech Transfer, and IP?

February 5, 2018

When Are Swashbuckling Experts Seemingly ‘Flooding’ a Court with Large Number of References?

November 15, 2017

Early Stage Biotech IP Strategy: Untangling the Chain of Title

March 21, 2017

Newly Approved Biosimilar Inflectra™ Market Launch Held Up in Court

April 12, 2016

Does the scope of immunity from assertions of patent infringement against U.S. government contractors under 28 U.S.C. § 1498 extend to acts of indirect infringement?

June 15, 2015

What’s the Intent? Comparing Induced Infringement and Willfulness

May 25, 2015